Pivot Park featured an episode discussing how FIGON facilitates interaction between stakeholders in drug development and the Dutch Medicines Days taking place on 7 and 8 October at CORPUS in Leiden.
Public source
Publisher name
Public post
In the Netherlands, drug development involves far more than pharmaceutical companies alone. Universities, regulators, science parks, pharmacists, pharmacologists, scient…
Company
Pivot Park
Europe’s foremost biopharmaceutical campus
- Industry
- Pharmaceutical Manufacturing
- Location
- Oss, NL
- Company size
- 11–50 employees
About Pivot Park
Pivot Park is the hub for companies and knowledge institutes in the biopharma industry. Over 1,000 people work at the campus at 60 start-ups, scale-ups and established companies specialised in transformational drug discoveries. Pivot Park offers sustainable real estate, facilities and services, gateways to knowledge, access to entrepreneurial expertise and a dynamic community. Pivot Park in Oss, the Netherlands, has everything that is required to develop Europe’s foremost biopharmaceutical campus for a community that will together improve global health.
See moreLatest activity
Latest activity from Pivot Park
5 signals
People
Pivot Park employee Miguel Rodriguez Fuentes from Sublin Therapeutics received the 2026 Pedro Hermkens Stipend.
Presence & Recognition
Pivot Park is hosting the PharmaNL Connection Day SDI event on 29 September to learn about the upcoming call, connect with Dutch pharmaceutical sector organisations, and explore potential collaborations.
Presence & Recognition
Pivot Park announced that Brigitte Drees and Klaas Poelstra were featured on the Leaders in Life Sciences podcast
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
pharma.be
pharma.be hosted a new A Talk in the Park episode featuring Caroline Ven and Frédéric Druck, CEO of bio.be, discussing Belgium's life sciences ecosystem, innovation, and collaboration across the sector.
Presence & Recognition
Health Holland
Health Holland featured bestuursvoorzitter Conny Helder and Jolande Zijlstra in the DEMPACT podcast discussing public-private collaboration and dementia research.
Presence & Recognition
Synthon
Synthon CEO Anish Mehta joined Thomas Dove on the Active Ingredients podcast by Fraser Dove International to discuss leadership in generics pharmaceuticals.
Presence & Recognition
Lonza
Lonza featured Nina Hentzen, Head of Preclinical Development Bioconjugates, as she shares how the company helps customers navigate early-stage bioconjugate development with confidence.
Presence & Recognition
Suttons Creek